CLINICAL_TRIALS
research
· 2026-01-21
Clinical Trial Update: The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders [Phase 1]
Summary
A Phase 1 clinical trial assessing the safety and efficacy of NouvSoma001 for neuromyelitis optica spectrum disorders is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tongji Hospital | Conditions: Neuromyelitis Optica Spectrum Disorders | Phase 1 | Status: RECRUITING